With the advent of whole genome-sequencing (WGS) studies, family-based designs enable sex-specific analysis approaches that can be applied to only affected individuals; tests using family-based designs are attractive because they are completely robust against the effects of population substructure. These advantages make family-based association tests (FBATs) that use siblings as well as parents especially suited for the analysis of late-onset diseases such as Alzheimer's Disease (AD). However, the application of FBATs to assess sex-specific effects can require additional filtering steps, as sensitivity to sequencing errors is amplified in this type of analysis. Here, we illustrate the implementation of robust analysis approaches and additional filtering steps that can minimize the chances of false positive-findings due to sex-specific sequencing errors. We apply this approach to two family-based AD datasets and identify four novel loci (GRID1, RIOK3, MCPH1, ZBTB7C) showing sex-specific association with AD risk. Following stringent quality control filtering, the strongest candidate is ZBTB7C (P inter = 1.83 × 10 −7 ), in which the minor allele of rs1944572 confers increased risk for AD in females and protection in males. ZBTB7C encodes the Zinc Finger and BTB Domain Containing 7C, a transcriptional repressor of membrane metalloproteases (MMP). Members of this MMP family were implicated in AD neuropathology.Alzheimer's disease (AD) is the most common form of dementia worldwide, with a substantial burden for not only patients, but their families, society and the healthcare system. The impact of the disease is expected to increase further by 2050, with a projected 13.9 million Americans to develop AD or related dementias 1 . Like most complex diseases, AD is caused by a mixture of genetic and environmental factors. Early-onset familial AD (monogenic) is caused by rare fully penetrant mutations in APP, PSEN1, PSEN2 genes 2 . The more prevalent form, late-onset (sporadic) AD, is caused by a complex polygenic architecture, including large-effect variants in the APOE gene 3 . Environmental and lifestyle factors also affect the prevalence of the disease, however this domain is less well elucidated to date. Although one of the strongest predictors for AD is age, there are several other risk factors, including race 4 , high blood pressure 5 , brain trauma 6 and sex 7-10 .Not only are women at twofold greater risk than men, the progression of the disease and neurodegeneration is more rapid among women versus men 11,12 . In contrast, men with AD have higher mortality, as compared to women 12,13 . Interactions between sex and APOE ε4 have been previously reported. For instance, Altmann et al. showed that women have greater AD risk in the presence of APOE ε4, and this APOE-related risk in women may